- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
Aeterna Zentaris’ Zoptrex granted licensing agreement for Australia and New Zealand
14 October 2016 • Author: Niamh Louise Marriott, Digital Content Producer
On 12 October 2016, Aeterna Zentaris signed an exclusive license agreement with Specialised Therapeutics Asia for its lead anti-cancer compound, Zoptrex, for the territories of Australia and New Zealand for an upfront payment plus milestones and royalties.
In line with their co-development agreement with Aeterna Zentaris, Ergomed will receive a portion of all revenues generated from the commercialisation of the product.
Zoptrex, a novel synthetic peptide carrier linked to doxorubicin, is currently in a fully-enrolled Phase 3 clinical trial in endometrial cancer. Aeterna Zentaris will, if the results of the trial warrant doing so, submit a new drug application for Zoptrex to the US Food and Drug Administration (FDA) in 2017. Zoptrex is the proposed tradename for zoptarelin doxorubicin. The proposed tradename is subject to approval by the FDA.
Dr Miroslav Reljanovic, CEO Ergomed, said,
“This licensing agreement for Australia and New Zealand adds another two territories to the overall coverage. In line with our strategy to expand our co-development business, we also recently announced a new partnership which together with this licensing agreement, further validates our hybrid business model.”
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) EUROGENTEC F.P.S. Food and Pharma Systems Srl IDBS JEOL Europe L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics